The stock has experienced significant volatility over the past six months, with a notable surge in mid-February 2026 to above $100, followed by a sharp decline back to the low $80s. Over the past month, the stock is down 8.48%, underperforming the S&P 500, which fell 5.25%. Over the past three months, the stock is down 2.92%, but this represents a relative strength of +1.71% compared to the S&P 500's -4.63% decline.

The current price of $83.02 is significantly below the 52-week high of $122.84, representing a drawdown of approximately 32%. It is, however, above the 52-week low of $73.21. The price action shows the stock has been in a downtrend since its February peak, with recent trading consolidating in the high $70s to low $80s range.

Revenue in Q4 2025 was $957.6 million, representing a year-over-year decline of 3.25%. Profitability has been inconsistent, with a significant net loss in Q2 2025 skewing the trailing twelve-month EPS to negative $0.02. However, the most recent quarter (Q4 2025) showed a net income of $105.2 million with a net margin of 11.0%, and the operating margin remains positive at 3.7%.

The company's financial health shows a debt-to-equity ratio of 1.25, indicating a leveraged balance sheet. The current ratio is a healthy 1.27. Cash flow generation is strong, with trailing twelve-month free cash flow reported at $659.2 million, providing solid liquidity for operations and shareholder returns via stock buybacks.

Operational efficiency metrics are mixed. Return on Equity (ROE) is negative at -6.3%, primarily due to the negative net income over the trailing period. However, Return on Assets (ROA) is positive at 12.4%, suggesting the company generates decent returns on its asset base despite profitability challenges in specific quarters.